Parexel and Sanofi are to undertake research to find out just how useful wearables are for patients and investigators in clinical trials. The promise of wearables is that they can improve data ...

DURHAM, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development ...

Four years after being taken private, Parexel has been sold again, with Goldman Sachs' private equity arm and EQT paying $8.5 billion to claim ownership of the contract research organisation.

The U.S.-based company plans to boost its headcount in India by more than 2,000 over the next three to five years, from about ...

Veteran Oncologist and Clinical Development expert to lead global medical strategy supporting patient-focused drug development and delivery DURHAM, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Parexel, ...